secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001104659-23-097804
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals raises $1.2M via private placement of preferred shares and warrants at $0.40
--------------------------------------------------------------------------------

- Issued 3M shares of Series A Preferred Stock and 3M warrants, each at $0.40, raising ~$1.2M from existing investors.
- Preferred shares convert to common stock after 6 months or earlier if stock price reaches $1.20 per share.
- Warrants exercisable at $0.40 per share for 5 years, also early conversion if $1.20 trigger met.
- Proceeds to fund development of NRX-101 for Suicidal Bipolar Depression and Chronic Pain, plus general corporate purposes.
- Certificate of Designation filed with Delaware authorizing up to 12M shares of Series A Preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465923097804/0001104659-23-097804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465923097804/tm2317653d12_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-097804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer